z-logo
Premium
A Test of the Ventilatory Response to Hypoxia and Hypercapnia for Clinical Use
Author(s) -
Hensley M. J.,
Read D. J. C.
Publication year - 1977
Publication title -
australian and new zealand journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.596
H-Index - 70
eISSN - 1445-5994
pISSN - 0004-8291
DOI - 10.1111/j.1445-5994.1977.tb04396.x
Subject(s) - hypercapnia , hypoxia (environmental) , medicine , pco2 , anesthesia , respiration , ventilation (architecture) , oxygen , chemistry , acidosis , mechanical engineering , organic chemistry , engineering , anatomy
Summary:A test of the ventilatory response to hypoxia and hypercapnia for clinical use . M. J. Hensley and D. J. C. Read, Aust. N.Z. J. Med ., 1977, 7 , pp. 362–367. A new technique is described for testing the ventilatory response to hypoxia and to hypercapnia The test consists of interposing 15–20 seconds of hypoxia in 3–4 minutes of rebreathing 7% CO 2 ; the hypoxia is induced by taking three to five breaths from a bag containing N 2 , and CO 2 at an identical level. When required, hypoxic tests can be performed at several different PCO 2 levels to define the interaction of hypoxic and hypercapnic stimuli In eight healthy subjects, 29 hypoxic tests were performed, at an average PCO 2 of 58 mm Hg (range 53–64). The correlation between ventilatory increments and 0 2 ‐desaturation was significant in 27 of the 29 tests (r = 0.81‐0.99). At the minimum 0 2 ‐saturation (average 85%; range 75–91%) there was a statistically significant ventilatory response to hypoxia in all 29 tests (average +60%; range +14 to +141%). At 90% O 2 ‐saturation, the average increment of ventilation was +48% This method has important theoretical and practical advantages for clinical studies: (i) the test involves only 15–20 seconds of hypoxia; (ii) since the hypoxic drive to breathing is greatly enhanced by hypercapnia only a mild degree of hypoxaemia is necessary to obtain a clearly defined response; (iii) the augmented ventilation, produced by rebreathing, allows N 2 to be rapidly introduced into the lungs without the need for voluntarily imposed deep breathing; (iv) the elevated PCO 2 increases cerebral blood flow and minimises brain tissue hypoxia. (v) Since rebreathing 7% CO 2 greatly reduces mixed venous‐arterial and cerebral tissue‐arterial PCO 2 differences, the cerebral tissue PCO 2 and CO 2 stimulus are virtually unaffected by both ventilatory and cerebral blood flow responses in this test

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here